PRECIPIO, INC. Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest
PRECIPIO, INC. (PRPO) had Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest of $14.76 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest
us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest · last filed 2026-08-14
- 2026-06-30: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $14.76M.
- 2026-03-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $14.17M.
- 2025-12-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $14.56M.
- 2025-09-30: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $13.75M.
| Period end | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest |
|---|---|
| 2026-06-30 | $14.76M 10-Q · filed 2026-08-14 |
| 2026-03-31 | $14.17M 10-Q · filed 2026-08-14 |
| 2025-12-31 | $14.56M 10-Q · filed 2026-08-14 |
| 2025-09-30 | $13.75M 10-Q · filed 2025-11-14 |
| 2025-06-30 | $12.29M 10-Q · filed 2026-08-14 |
| 2025-03-31 | $11.70M 10-Q · filed 2026-08-14 |
| 2024-12-31 | $12.09M 10-Q · filed 2026-08-14 |
| 2024-09-30 | $11.95M 10-Q · filed 2025-11-14 |
| 2024-06-30 | $12.12M 10-Q · filed 2025-11-14 |
| 2024-03-31 | $12.77M 10-Q · filed 2025-08-13 |
| 2023-12-31 | $14.43M 10-Q · filed 2025-11-14 |
| 2023-09-30 | $13.00M 10-Q · filed 2024-11-06 |
| 2023-06-30 | $14.09M 10-Q · filed 2024-11-06 |
| 2023-03-31 | $14.22M 10-Q · filed 2024-08-13 |
| 2022-12-31 | $16.37M 10-K · filed 2025-03-27 |
| 2022-09-30 | $18.25M 10-Q · filed 2023-11-13 |
| 2022-06-30 | $20.57M 10-Q · filed 2023-11-13 |
| 2022-03-31 | $22.25M 10-Q · filed 2023-08-11 |
| 2021-12-31 | $24.60M 10-K · filed 2024-03-29 |
| 2021-09-30 | $25.92M 10-Q · filed 2022-11-10 |
| 2021-06-30 | $27.26M 10-Q · filed 2022-11-10 |
| 2021-03-31 | $14.56M 10-Q · filed 2022-08-11 |
| 2020-12-31 | $14.16M 10-K · filed 2023-03-30 |
| 2020-09-30 | $13.86M 10-Q · filed 2021-11-12 |
| 2020-06-30 | $12.63M 10-Q · filed 2021-11-12 |
| 2020-03-31 | $11.29M 10-Q · filed 2021-08-12 |
| 2019-12-31 | $13.21M 10-K · filed 2022-03-30 |
| 2019-09-30 | $15.29M 10-Q · filed 2020-11-13 |
| 2019-06-30 | $14.23M 10-Q · filed 2020-11-13 |
| 2019-03-31 | $9.83M 10-Q · filed 2020-08-13 |
| 2018-12-31 | $6.12M 10-K · filed 2021-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |